(FXI) China Large-Cap - Overview
Etf: Technology, Financials, Energy, Consumer Discretionary
Dividends
| Dividend Yield | 2.49% |
| Yield on Cost 5y | 2.01% |
| Yield CAGR 5y | 12.14% |
| Payout Consistency | 92.9% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 24.6% |
| Relative Tail Risk | -6.69% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.77 |
| Alpha | 9.80 |
| Character TTM | |
|---|---|
| Beta | 0.682 |
| Beta Downside | 0.604 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.71% |
| CAGR/Max DD | 0.33 |
Description: FXI China Large-Cap January 09, 2026
The iShares China Large-Cap ETF (FX I) seeks to track an index that captures the performance of the biggest Chinese companies listed on the Hong Kong Stock Exchange and accessible to foreign investors. At least 80 % of the fund’s assets are invested in the index’s component securities or in securities that are economically equivalent, and the ETF is classified as non-diversified because it concentrates on a relatively narrow set of large-cap stocks.
Key data points as of early 2026: the fund holds roughly 50 % of its assets in the financial sector (state-owned banks and insurers), about 20 % in consumer discretionary (e.g., auto and retail), and the remainder in technology and industrials. Its expense ratio is 0.74 % and total assets under management are approximately $12 billion. Recent macro drivers include China’s target 5 % real-GDP growth for 2026, ongoing reforms to the property market, and the “dual circulation” policy that aims to boost domestic consumption, all of which directly affect the earnings outlook of the ETF’s top holdings.
If you want a more granular, data-driven assessment of FXI’s risk-adjusted performance and sector sensitivities, a quick look at ValueRay’s analytics could be worthwhile.
What is the price of FXI shares?
Over the past week, the price has changed by -6.33%, over one month by -4.33%, over three months by -2.90% and over the past year by +22.64%.
Is FXI a buy, sell or hold?
What are the forecasts/targets for the FXI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 40.5 | 5.9% |
FXI Fundamental Data Overview January 31, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 6.58b USD (6.58b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 6.58b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 6.58b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.43% (E(6.58b)/V(6.58b) * Re(8.43%) + (debt-free company))
Discount Rate = 8.43% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)